Lars Bastholt

Researcher Next ID · RN-006751

Researcher · Medicine

Odense, Denmark

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Cutaneous Melanoma Detection and Management

Cancer Immunotherapy and Biomarkers

Melanoma and MAPK Pathways

Thyroid Cancer Diagnosis and Treatment

CAR-T cell therapy research

Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Nature · 2020 · https://doi.org/10.1038/s41586-019-1914-8
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1910836
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1611299
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1504030
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)60421-9

No projects listed.